Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$86.42 - $109.81 $1.43 Million - $1.82 Million
-16,582 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$98.56 - $119.91 $1.07 Million - $1.3 Million
10,864 Added 190.0%
16,582 $1.79 Million
Q3 2021

Nov 09, 2021

BUY
$91.91 - $110.37 $525,541 - $631,095
5,718 New
5,718 $626,000
Q3 2020

Nov 16, 2020

SELL
$55.23 - $79.93 $145,420 - $210,455
-2,633 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$30.2 - $56.98 $79,516 - $150,028
2,633 New
2,633 $146,000
Q3 2019

Nov 12, 2019

SELL
$23.0 - $27.97 $671,140 - $816,164
-29,180 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$22.81 - $28.48 $665,595 - $831,046
29,180 New
29,180 $702,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.